ERBB2 and breast carcinoma: However, entinostat-driven inhibition of MDSC activity combined with ICI resulted in the tumor regression and longer tumor-free survival by improving the infiltration and function of granzymeB+CD8+ T cells in mouse models of HER2 transgenic breast cancer and the Panc02 metastatic pancreatic cancer mouse models (3, 67).